Gratus Capital’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $1.24M | Buy |
12,801
+2,975
| +30% | +$274K | 0.05% | 162 |
|
|
2024
Q1 | $885K | Buy |
9,826
+318
| +3% | +$26.9K | 0.04% | 177 |
|
|
2023
Q4 | $758K | Sell |
9,508
-540
| -5% | -$40.6K | 0.04% | 159 |
|
|
2023
Q3 | $714K | Buy |
10,048
+141
| +1% | +$10.5K | 0.05% | 154 |
|
|
2023
Q2 | $763K | Sell |
9,907
-72
| -0.7% | -$5.57K | 0.05% | 155 |
|
|
2023
Q1 | $750K | Sell |
9,979
-135
| -1% | -$10K | 0.06% | 136 |
|
|
2022
Q4 | $797K | Hold |
10,114
| – | – | 0.07% | 139 |
|
|
2022
Q3 | $711K | Sell |
10,114
-360
| -3% | -$28.2K | 0.08% | 129 |
|
|
2022
Q2 | $839K | Buy |
10,474
+281
| +3% | +$22K | 0.09% | 112 |
|
|
2022
Q1 | $773K | Hold |
10,193
| – | – | 0.07% | 123 |
|
|
2021
Q4 | $870K | Hold |
10,193
| – | – | 0.08% | 116 |
|
|
2021
Q3 | $770K | Hold |
10,193
| – | – | 0.08% | 114 |
|
|
2021
Q2 | $829K | Sell |
10,193
-10,018
| -50% | -$819K | 0.09% | 111 |
|
|
2021
Q1 | $1.59M | Hold |
20,211
| – | – | 0.19% | 99 |
|
|
2020
Q4 | $1.73M | Sell |
20,211
-1,300
| -6% | -$107K | 0.23% | 88 |
|
|
2020
Q3 | $1.66M | Sell |
21,511
-600
| -3% | -$45.7K | 0.26% | 88 |
|
|
2020
Q2 | $1.62M | Sell |
22,111
-300
| -1% | -$21.3K | 0.27% | 84 |
|
|
2020
Q1 | $1.49M | Sell |
22,411
-3,699
| -14% | -$261K | 0.28% | 89 |
|
|
2019
Q4 | $1.8M | Sell |
26,110
-214
| -0.8% | -$14.6K | 0.27% | 93 |
|
|
2019
Q3 | $1.94M | Buy |
26,324
+21
| +0.1% | +$1.52K | 0.32% | 87 |
|
|
2019
Q2 | $1.89M | Sell |
26,303
-979
| -4% | -$69.5K | 0.31% | 87 |
|
|
2019
Q1 | $1.87M | Buy |
27,282
+23
| +0.1% | +$1.49K | 0.31% | 88 |
|
|
2018
Q4 | $1.62M | Sell |
27,259
-227
| -0.8% | -$14.2K | 0.33% | 87 |
|
|
2018
Q3 | $1.84M | Sell |
27,486
-528
| -2% | -$35.2K | 0.25% | 82 |
|
|
2018
Q2 | $1.82M | Sell |
28,014
-3,188
| -10% | -$209K | 0.27% | 78 |
|
|
2018
Q1 | $2.24M | Sell |
31,202
-3,181
| -9% | -$229K | 0.32% | 76 |
|
|
2017
Q4 | $2.59M | Buy |
34,383
+19
| +0.1% | +$1.39K | 0.34% | 73 |
|
|
2017
Q3 | $2.5M | Buy |
34,364
+6
| +0% | +$432 | 0.35% | 68 |
|
|
2017
Q2 | $2.55M | Sell |
34,358
-51
| -0.1% | -$3.79K | 0.36% | 70 |
|
|
2017
Q1 | $2.52M | Sell |
34,409
-97
| -0.3% | -$6.79K | 0.36% | 70 |
|
|
2016
Q4 | $2.26M | Sell |
34,506
-133
| -0.4% | -$9.12K | 0.34% | 72 |
|
|
2016
Q3 | $2.57M | Buy |
34,639
+18
| +0.1% | +$1.33K | 0.38% | 65 |
|
|
2016
Q2 | $2.53M | Buy |
34,621
+31,293
| +940% | +$2.23M | 0.37% | 62 |
|
|
2016
Q1 | $235K | Hold |
3,328
| – | – | 0.05% | 61 |
|
|
2015
Q4 | $222K | Hold |
3,328
| – | – | 0.05% | 86 |
|
|
2015
Q3 | $211K | Hold |
3,328
| – | – | 0.05% | 88 |
|
|
2015
Q2 | $218K | Hold |
3,328
| – | – | 0.05% | 87 |
|
|
2015
Q1 | $231K | Hold |
3,328
| – | – | 0.05% | 86 |
|
|
2014
Q4 | $230K | Buy |
+3,328
| New | +$225K | 0.05% | 72 |
|
Other funds holding CL
Gratus Capital's CL Position: Q2 2024 in Review
Gratus Capital increased its Colgate-Palmolive (CL) stake by 30% in Q2 2024, buying an estimated $274K and bringing the position to 12,801 shares worth $1.24M. The position accounts for 0.05% of the portfolio, ranked #162.
Gratus Capital first reported a position in CL in Q4 2014 and has held it in 39 quarters since. The position peaked at $2.59M in Q4 2017. 1,819 funds tracked by Wall St. Rank hold CL as of Q2 2024.
- Gratus Capital held 12,801 shares of Colgate-Palmolive worth $1.24M as of Q2 2024.
- Gratus Capital bought 2,975 Colgate-Palmolive shares in Q2 2024, an estimated $274K.
- Colgate-Palmolive made up 0.05% of Gratus Capital's portfolio in Q2 2024, its #162 holding.
- Gratus Capital first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 39 quarters since.
- Gratus Capital's Colgate-Palmolive position peaked at $2.59M in Q4 2017.
- 1,819 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2024.
Based on Gratus Capital's 13F filing for Q2 2024, filed 25 Jul 2024.